Khondrion Starts Phase 2 for Debilitating Post-COVID Fatigue
19 May 2026 //
GLOBENEWSWIRE
Khondrion Doses First Patient in Phase 3 Sonlicromanol Trial
16 Apr 2026 //
FIRSTWORD PHARMA
Khondrion Receives FDA Clearance for Sonlicromanol Phase 3
14 Nov 2024 //
GLOBENEWSWIRE
Khondrion`s Ph 2b Data on Sonlicromanol in Mitochondrial Disease
07 Nov 2024 //
GLOBENEWSWIRE
Khondrion announces grant of patents in the US and Europe for sonlicromanol
01 Nov 2023 //
PR NEWSWIRE

Market Place
Sourcing Support